Coign Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$874K Buy
3,440
+42
+1% +$9.79K 0.39% 44
2026
Q1
$831K Sell
3,398
-776
-19% -$181K 0.44% 33
2025
Q4
$864K Buy
4,174
+63
+2% +$12.5K 0.45% 36
2025
Q3
$762K Buy
4,111
+87
+2% +$14.9K 0.42% 41
2025
Q2
$615K Buy
4,024
+76
+2% +$11.7K 0.42% 55
2025
Q1
$655K Sell
3,948
-174
-4% -$27.2K 0.5% 39
2024
Q4
$596K Buy
+4,122
New +$639K 0.55% 49

Other funds holding JNJ

Coign Capital Advisors's JNJ Position: Q2 2026 in Review

Coign Capital Advisors increased its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, buying an estimated $9.79K and bringing the position to 3,440 shares worth $874K. The position accounts for 0.39% of the portfolio, ranked #44.

Coign Capital Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Coign Capital Advisors held 3,440 shares of Johnson & Johnson worth $874K as of Q2 2026.
  • Coign Capital Advisors bought 42 Johnson & Johnson shares in Q2 2026, an estimated $9.79K.
  • Johnson & Johnson made up 0.39% of Coign Capital Advisors's portfolio in Q2 2026, its #44 holding.
  • Coign Capital Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Coign Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.